Xie Laiping, Zhang Yan-Ling, Zhang Zhong-Yin
Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Biochemistry. 2002 Mar 26;41(12):4032-9. doi: 10.1021/bi015904r.
Although members of the protein tyrosine phosphatase (PTPase) family share a common mechanism of action (hydrolysis of phosphotyrosine), the cellular processes in which they are involved can be both highly specialized and fundamentally important. Identification of cellular PTPase substrates will help elucidate the biological functions of individual PTPases. Two types of substrate-trapping mutants are being used to isolate PTPase substrates. In the first, the active site Cys residue is replaced by a Ser (e.g., PTP1B/C215S) while in the second, the general acid Asp residue is substituted by an Ala (e.g., PTP1B/D181A). Unfortunately, only a limited number of PTPase substrates have been identified with these two mutants, which are usually relatively abundant cellular proteins. Based on mechanistic considerations, we seek to create novel PTPase mutants with improved substrate-trapping properties. Kinetic and thermodynamic characterization of the newly designed PTP1B mutants indicates that PTP1B/D181A/Q262A displays lower catalytic activity than that of D181A. In addition, D181A/Q262A also possesses 6- and 28-fold higher substrate-binding affinity than those of D181A and C215S, respectively. In vivo substrate-trapping experiments indicate that D181A/Q262A exhibits much higher affinity than both D181A and C215S for a bona fide PTP1B substrate, the epidermal growth factor receptor. Moreover, D181A/Q262A can also identify novel, less abundant substrates, that are missed by D181A. Thus, this newly developed and improved substrate-trapping mutant can serve as a powerful affinity reagent to isolate and purify both high- and low-abundant protein substrates. Given that both Asp181 and Gln262 are invariant among the PTPase family, it is predicted that this improved substrate-trapping mutant would be applicable to all members of PTPases for substrate identification.
尽管蛋白质酪氨酸磷酸酶(PTPase)家族成员具有共同的作用机制(磷酸酪氨酸水解),但它们所涉及的细胞过程可能既高度专业化又至关重要。鉴定细胞PTPase底物将有助于阐明单个PTPase的生物学功能。目前正在使用两种类型的底物捕获突变体来分离PTPase底物。第一种是将活性位点的半胱氨酸残基替换为丝氨酸(例如,PTP1B/C215S),而第二种是将通用酸天冬氨酸残基替换为丙氨酸(例如,PTP1B/D181A)。不幸的是,使用这两种突变体仅鉴定出有限数量的PTPase底物,这些底物通常是细胞中相对丰富的蛋白质。基于机制上的考虑,我们试图创建具有改进的底物捕获特性的新型PTPase突变体。对新设计的PTP1B突变体的动力学和热力学表征表明,PTP1B/D181A/Q262A的催化活性低于D181A。此外,D181A/Q262A与D181A和C215S相比,分别具有高6倍和28倍的底物结合亲和力。体内底物捕获实验表明,对于真正的PTP1B底物表皮生长因子受体,D181A/Q262A的亲和力比D181A和C215S都高得多。此外,D181A/Q262A还可以鉴定出D181A遗漏的新的、丰度较低的底物。因此,这种新开发和改进的底物捕获突变体可以作为一种强大的亲和试剂,用于分离和纯化高丰度和低丰度的蛋白质底物。鉴于天冬氨酸181和谷氨酰胺262在PTPase家族中都是不变的,预计这种改进的底物捕获突变体将适用于所有PTPase成员以进行底物鉴定。